130 related articles for article (PubMed ID: 18729096)
41. A new orally active antidiabetic vanadyl complex--bis(alpha-furancarboxylato)oxovanadium(IV).
Xie M; Gao L; Li L; Liu W; Yan S
J Inorg Biochem; 2005 Feb; 99(2):546-51. PubMed ID: 15621288
[TBL] [Abstract][Full Text] [Related]
42. Investigation of a Cu(II)-poly(gamma-glutamic acid) complex in aqueous solution and its insulin-mimetic activity.
Karmaker S; Saha TK; Sakurai H
Macromol Biosci; 2007 Apr; 7(4):456-66. PubMed ID: 17429807
[TBL] [Abstract][Full Text] [Related]
43. Bis(hinokitiolato)zinc complex ([Zn(hkt)2]) activates Akt/protein kinase B independent of insulin signal transduction.
Naito Y; Yoshikawa Y; Masuda K; Yasui H
J Biol Inorg Chem; 2016 Jul; 21(4):537-48. PubMed ID: 27251140
[TBL] [Abstract][Full Text] [Related]
44. The therapeutic potential of insulin-mimetic vanadium complexes.
Sakurai H; Yasui H; Adachi Y
Expert Opin Investig Drugs; 2003 Jul; 12(7):1189-203. PubMed ID: 12831353
[TBL] [Abstract][Full Text] [Related]
45. [Treatment of diabetes in experimental animals by metallocomplexes].
Sakurai H
Yakugaku Zasshi; 2008 Mar; 128(3):317-22. PubMed ID: 18311049
[TBL] [Abstract][Full Text] [Related]
46. Anti-diabetic vanadyl complexes reduced Alzheimer's disease pathology independent of amyloid plaque deposition.
Dong Y; Stewart T; Zhang Y; Shi M; Tan C; Li X; Yuan L; Mehrotra A; Zhang J; Yang X
Sci China Life Sci; 2019 Jan; 62(1):126-139. PubMed ID: 30136058
[TBL] [Abstract][Full Text] [Related]
47. Synthesis, characterization and anti-diabetic therapeutic potential of a new benzyl acid-derivatized kojic acid vanadyl complex.
Wei YB; Yang XD
Biometals; 2012 Dec; 25(6):1261-8. PubMed ID: 23015214
[TBL] [Abstract][Full Text] [Related]
48. Synthesis, spectroscopic, structural and thermal characterizations of vanadyl(IV) adenine complex prospective as antidiabetic drug agent.
El-Megharbel SM; Hamza RZ; Refat MS
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Jan; 135():850-64. PubMed ID: 25150436
[TBL] [Abstract][Full Text] [Related]
49. Effect of Vanadyl Rosiglitazone, a New Insulin-Mimetic Vanadium Complexes, on Glucose Homeostasis of Diabetic Mice.
Jiang P; Dong Z; Ma B; Ni Z; Duan H; Li X; Wang B; Ma X; Wei Q; Ji X; Li M
Appl Biochem Biotechnol; 2016 Nov; 180(5):841-851. PubMed ID: 27240663
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and insulinomimetic activities of novel mono- and tetranuclear oxovanadium(IV) complexes with 3-hydroxypyridine-2-carboxylic acid.
Nakai M; Obata M; Sekiguchi F; Kato M; Shiro M; Ichimura A; Kinoshita I; Mikuriya M; Inohara T; Kawabe K; Sakurai H; Orvig C; Yano S
J Inorg Biochem; 2004 Jan; 98(1):105-12. PubMed ID: 14659639
[TBL] [Abstract][Full Text] [Related]
51. A small molecule inhibitor for phosphatase and tensin homologue deleted on chromosome 10 (PTEN).
Rosivatz E; Matthews JG; McDonald NQ; Mulet X; Ho KK; Lossi N; Schmid AC; Mirabelli M; Pomeranz KM; Erneux C; Lam EW; Vilar R; Woscholski R
ACS Chem Biol; 2006 Dec; 1(12):780-90. PubMed ID: 17240976
[TBL] [Abstract][Full Text] [Related]
52. Is the hypoglycemic action of vanadium compounds related to the suppression of feeding?
Huang M; Wu Y; Wang N; Wang Z; Zhao P; Yang X
Biol Trace Elem Res; 2014 Mar; 157(3):242-8. PubMed ID: 24446192
[TBL] [Abstract][Full Text] [Related]
53. Structural origins of the insulin-mimetic activity of bis(acetylacetonato)oxovanadium(IV).
Makinen MW; Brady MJ
J Biol Chem; 2002 Apr; 277(14):12215-20. PubMed ID: 11815612
[TBL] [Abstract][Full Text] [Related]
54. [A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus].
Ozawa H; Murai Y; Ozawa T
Yakushigaku Zasshi; 2003; 38(1):11-27. PubMed ID: 14570054
[TBL] [Abstract][Full Text] [Related]
55. Metallokinetic characteristics of antidiabetic bis(allixinato)oxovanadium(IV)-related complexes in the blood of rat.
Yasui H; Adachi Y; Katoh A; Sakurai H
J Biol Inorg Chem; 2007 Aug; 12(6):843-53. PubMed ID: 17503093
[TBL] [Abstract][Full Text] [Related]
56. Ibervillea sonorae (Cucurbitaceae) induces the glucose uptake in human adipocytes by activating a PI3K-independent pathway.
Zapata-Bustos R; Alonso-Castro AJ; Gómez-Sánchez M; Salazar-Olivo LA
J Ethnopharmacol; 2014 Mar; 152(3):546-52. PubMed ID: 24534528
[TBL] [Abstract][Full Text] [Related]
57. [Insulin-mimetic property of vanadium compounds].
Korbecki J; Baranowska-Bosiacka I; Gutowska I; Chlubek D
Postepy Biochem; 2016; 62(1):60-65. PubMed ID: 28132446
[TBL] [Abstract][Full Text] [Related]
58. Vanadium chemistry and biochemistry of relevance for use of vanadium compounds as antidiabetic agents.
Crans DC; Mahroof-Tahir M; Keramidas AD
Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):17-24. PubMed ID: 8927035
[TBL] [Abstract][Full Text] [Related]
59. An anionic inositol phosphate glycan pseudotetrasaccharide exhibits high insulin-mimetic activity in rat adipocytes.
Chakraborty N; d'Alarcao M
Bioorg Med Chem; 2005 Dec; 13(24):6732-41. PubMed ID: 16115771
[TBL] [Abstract][Full Text] [Related]
60. Organo-vanadium compounds are potent activators of the protein kinase B signaling pathway and protein tyrosine phosphorylation: mechanism of insulinomimesis.
Mehdi MZ; Srivastava AK
Arch Biochem Biophys; 2005 Aug; 440(2):158-64. PubMed ID: 16055077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
